Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
66.4M
-
Number of holders
-
119
-
Total 13F shares, excl. options
-
47.6M
-
Shares change
-
+7.04M
-
Total reported value, excl. options
-
$1.01B
-
Value change
-
+$147M
-
Put/Call ratio
-
2
-
Number of buys
-
75
-
Number of sells
-
-42
-
Price
-
$21.27
Significant Holders of RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) as of Q1 2021
145 filings reported holding RYTM - RHYTHM PHARMACEUTICALS, INC. - COM as of Q1 2021.
RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) has 119 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 47.6M shares
of 66.4M outstanding shares and own 71.65% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (6.01M shares), NEA Management Company, LLC (4.91M shares), RA CAPITAL MANAGEMENT, L.P. (4.87M shares), JANUS HENDERSON GROUP PLC (4.09M shares), BAKER BROS. ADVISORS LP (3.48M shares), BlackRock Inc. (3.15M shares), FEDERATED HERMES, INC. (3.11M shares), STATE STREET CORP (2.44M shares), VANGUARD GROUP INC (2.25M shares), and DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (1.99M shares).
This table shows the top 119 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.